Category: Federal Forum Posters
Purpose: Prevalence rates for mental health disorders are high among patients with HIV, with around 35% of patients and 49% of veterans having comorbid depression. Non-adherence is the primary reason for treatment failure amongst those infected with HIV, and depression is a barrier to adherence of antiretroviral therapy (ART). Additionally, depression has been linked to poor attendance to HIV clinic appointments, accelerated clinical progression of HIV, and higher mortality rates. Therefore, identifying and treating patients with coexisting mental health conditions, especially depression, can help to improve adherence and prevent treatment failure.
Methods: This study will evaluate the benefit of implementing a protocol for depression screenings (with future plan to expand screenings to other mental health conditions, including substance use disorders) into an HIV clinic utilizing both pharmacy and psychiatry residents. The protocol outlines the incorporation of depression screenings using the patient health questionnaire (PHQ-9). Those screened positive will be further evaluated, and based on the individualized scores and other clinical factors will either be referred to mental health or medications will be started, adjusted, or changed. In addition to PHQ-9 scores and associated treatment, the following data will be collected: patient age, gender, ethnicity, past medical history, history of medications used, baseline labs, length of time since diagnosis of HIV, CD4 count, viral load, and electrocardiograms. All data will be recorded without patient identifiers and maintained confidentially. PHQ-9 scores and treatment will be evaluated and assessed for similar rates of adherence, viral load, and CD4 count between those who were treated after a positive screen compared to those with a negative screen.
Results: not applicable
Conclusion: not applicable
Eileen Mintz– PGY1 Pharmacy Practice Resident, Kingsbrook Jewish Medical Center, Elizabeth, NJ